Healthcare & Life Sciences

Lysosomal Therapeutics, Inc.

United States

series-a

Stage

Investors

About

Lysosomal Therapeutics, Inc. is a biotechnology company focused on developing therapies that target lysosomal biology to treat lysosomal and related diseases.

Explore Lysosomal Therapeutics, Inc.'s full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.